Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain

Journal of Neurochemistry

Volumn 103, Issue 6, 2007, Pages 2462-2470

  Liang, Zhihou ^a,b   Liu, Fei ^a   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a   Gong, Cheng Xin ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Calpain; cAMP response element binding protein; Protein kinase

Indexed keywords

CALPAIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; CALCIUM; CALCIUM SIGNALING; CALPAIN; CATALYTIC DOMAIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; NEURONS; PHOSPHORYLATION;

EID: 36448978859     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04942.x     Document Type: Article

References (42)

1. Aragon B., Poussard S., Dulong S., Touyarot K., Dargelos E., Brustis J. J., Levieux D., Ducastaing A. Cottin P. (2002) Protein kinase Calpha is a calpain target in cultured embryonic muscle cells. Mol. Cell. Biochem. 231, 97 106.
2. Barco A., Pittenger C. Kandel E. R. (2003) CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin. Ther. Targets 7, 101 114.
3. Braak H. Braak E. (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271 284.
4. 2+ channel activity by cAMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 94, 11067 11072.
5. Cadd G. McKnight G. S. (1989) Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. Neuron 3, 71 79.
6. Chang A., Li P. P. Warsh J. J. (2003) Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. J. Neurochem. 84, 781 791.
7. Cohen P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453 508.
8. Foss K. B., Simard J., Bérubé D., Beebe S. J., Sandberg M., Grzeschik K. H., Gagné R., Hansson V. Jahnsen T. (1992) Localization of the catalytic subunit C gamma of the cAMP-dependent protein kinase gene (PRKACG) to human chromosome region 9q13. Cytogenet. Cell Genet. 60, 22 25.
9. Gamm D. M., Baude E. J. Uhler M. D. (1996) The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. J. Biol. Chem. 271, 15736 15742.
10. Gong C.-C.-X., Singh T. J., Grundke-Iqbal I. Iqbal K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 3, 921 927.
11. Gong C.-X., Shaikh S., Wang J.-Z, Zaidi T., Grundke-Iqbal I. Iqbal K. (1995) Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 2, 732 738.
12. Gong B., Vitolo O. V., Trinchese F., Liu S., Shelanski M. Arancio O. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114, 1624 1634.
13. Hegde A. N., Goldberg A. L. Schwartz J. H. (1993) Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: a molecular mechanism underlying long-term synaptic plasticity. Proc. Natl Acad. Sci. USA 90, 7436 7440.
14. Jicha G. A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J. Davies P. (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 19, 7486 7494.
15. Josselyn S. A. Nguyen P. V. (2005) CREB, synapses and memory disorders: past progress and future challenges. Curr. Drug. Targets CNS Neurol. Disord. 4, 481 497.
16. Kennett S. B., Roberts J. D. Olden K. (2004) Requirement of protein kinase C micro activation and calpain-mediated proteolysis for arachidonic acid-stimulated adhesion of MDA-MB-435 human mammary carcinoma cells to collagen type IV. J. Biol. Chem. 279, 3300 3307.
17. Kim S. H., Nairn A. C., Cairns N. Lubec G. (2001) Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease. J. Neural Transm. Suppl. 61, 263 272.
18. Liu S. J., Zhang J. Y., Li H. L., Fang Z. Y., Wang Q., Deng H. M., Gong C. X., Grundke-Iqbal I., Iqbal K. Wang J. Z. (2004) Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J. Biol. Chem. 279, 50078 50088.
19. Liu F., Grundke-Iqbal I., Iqbal K., Oda Y., Tomizawa K. Gong C. X. (2005a) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J. Biol. Chem. 280, 37755 37762.
20. Liu F., Grundke-Iqbal I., Iqbal K. Gong C.-X. (2005b) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 8, 1942 1950.
21. Liu F., Liang Z., Shi J., Yin D., El-Akkad E., Grundke-Iqbal I., Iqbal K. Gong C. X. (2006) PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. FEBS Lett. 580, 6269 6274.
22. Matsuzaki K., Yamakuni T., Hashimoto M., Haque A. M., Shido O., Mimaki Y., Sashida Y. Ohizumi Y. (2006) Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci. Lett. 400, 230 234.
23. Mattson M. P. Chan S. L. (2003) Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34, 385 397.
24. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G. Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479 486.
25. Murray K. J., England P. J., Lynham J. A., Mills D., Schmitz-Peiffer C. Reeves M. L. (1990) Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem. J. 267, 703 708.
26. Nagakura A., Niimura M. Takeo S. (2002) Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br. J. Pharmacol. 135, 1783 1793.
27. Patzke H. Tsai L. H. (2002) Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J. Biol. Chem. 277, 8054 8060.
28. Pei J. J., Gong C. X., Iqbal K., Grundke-Iqbal I., Wu Q. L., Winblad B. Cowburn R. F. (1998) Subcellular distribution of protein phosphates and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J. Neural. Transm. 105, 69 83.
29. Pittenger C., Fasano S., Mazzocchi-Jones D., Dunnett S. B., Kandel E. R. Brambilla R. (2006) Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice. J. Neurosci. 26, 2808 2813.
30. Puzzo D., Vitolo O., Trinchese F., Jacob J. P., Palmeri A. Arancio O. (2005) Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J. Neurosci. 25, 6887 6897.
31. Qi M., Zhuo M., Skalhegg B. S., Brandon E. P., Kandel E. R., McKnight G. S. Idzerda R. L. (1996) Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 93, 1571 1576.
32. Raynaud F. Marcilhac A. (2006) Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J. 273, 3437 3443.
33. Reddy P. H. McWeeney S. (2006) Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol. Aging 27, 1060 1077.
34. Saito K., Elce J. S., Hamos J. E. Nixon R. A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl Acad. Sci. USA 90, 2628 2632.
35. Su Y., Ryder J. Ni B. (2003) Inhibition of Abeta production and APP maturation by a specific PKA inhibitor. FEBS Lett. 546, 407 410.
36. Tully T., Bourtchouladze R., Scott R. Tallman J. (2003) Targeting the CREB pathway for memory enhancers. Nat. Rev. Drug Discov. 2, 267 277.
37. Veeranna, Kaji T., Boland B. et al. (2004) Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am. J. Pathol. 165, 795 805.
38. Wang J. Z., Grundke-Iqbal I. Iqbal K. (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25, 59 68.
39. Wong W. Scott J. D. (2004) AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5, 959 970.
40. Wu H. Y., Tomizawa K., Oda Y., Wei F. Y., Lu Y. F., Matsushita M., Li S. T., Moriwaki A. Matsui H. (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929 4940.
41. Yamamoto-Sasaki M., Ozawa H., Saito T., Rösler M. Riederer P. (1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 824, 300 303.
42. Zimmerman U. J., Wang M., Nelson J. B., Ekwunife F. S. Liu L. (1996) Secretagogue-induced proteolysis of cAMP-dependent protein kinase in intact rat alveolar epithelial type II cells. Biochim. Biophys. Acta 1311, 117 123.